SOURCES SOUGHT
65 -- 1st Tier Newborn Screening Internal Standard Kits
- Notice Date
- 8/7/2025 12:38:36 PM
- Notice Type
- Sources Sought
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- CDC OFFICE OF ACQUISITION SERVICES ATLANTA GA 30333 USA
- ZIP Code
- 30333
- Solicitation Number
- 000HCNBE-2025-93380
- Response Due
- 8/11/2025 9:00:00 AM
- Archive Date
- 08/26/2025
- Point of Contact
- Staci Boykin
- E-Mail Address
-
zwh7@cdc.gov
(zwh7@cdc.gov)
- Description
- SMALL BUSINESS SOURCES SOUGHT ONLY This small business sources sought notice is issued solely for information and planning purposes � it does not constitute a solicitation or a promise to issue a solicitation in the future. This small business sources sought notice does not commit the Government to contract for any supply or service. The Government is not at this time seeking offers. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement. The small business sources sought respondents are advised that the Government will not pay for any information or costs incurred in response to this small business sources sought notice; all costs associated with responding to this notice will be solely at the interested party�s expense. Not responding to this notice does not preclude participation in any future solicitation, if any is issued. If a solicitation is released, it will be issued via SAM.gov. It is the responsibility of the potential offerors to monitor this site for additional information pertaining to this requirement, if any. RESPONSES: Interested parties believing that they possess the expertise and experience to meet the Government's needs described in the attached salient characteristics are invited to submit a capability statement with their technical and management capabilities addressing the requirements. Interested parties are requested to include the following information in their response: Company name, address, phone number; UEI and CAGE Code as registered in the System for Award Management (SAM) at http://www.sam.gov/ Business size and Classification (e.g., 8(a), HUBZone, etc.) pursuant to the applicable NAICS code of 325413 In-vitro diagnostic substance manufacturing Small Business Administration Business Opportunity Specialist (name, email address, phone number) if applicable. Point(s) of contact including e-mail addresses and telephone numbers for contacts. Submission Instructions: Responses are due via email on or before August 11, 2025, at 12:00 p.m. Eastern Time to Staci Boykin, email address: zwh7@cdc.gov. Only emailed responses will be accepted. Copy and paste into subject line: Response to small business sources sought for 1st Tier Newborn Screening Internal Standard Kits for (insert your company name). Late responses will not be accepted. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in the response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/a3e702263aeb44d0a3c5d13d6a86af19/view)
- Place of Performance
- Address: Atlanta, GA, USA
- Country: USA
- Country: USA
- Record
- SN07542706-F 20250809/250807230102 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |